Travel Medicine

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023
FDA Alert
fda
FDA Alert
Second OTC Naloxone Nasal Spray Approved by FDA
09/28/2023
Anthony Calabro, MA
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
09/28/2023